Change in vBMD of Combination Therapy of Teriparatide and Denosumab in Osteoporosis at 18 Months: How Much Difference Does It Make on Spine vBMD? | Synapse
March 3, 2026
Change in vBMD of Combination Therapy of Teriparatide and Denosumab in Osteoporosis at 18 Months: How Much Difference Does It Make on Spine vBMD?
Key Points
Combination therapy with teriparatide and denosumab significantly improves spine vBMD.
Participants experienced a noteworthy increase in vBMD after 18 months of treatment.
Assessment included measurements of vBMD following therapeutic intervention.
Findings suggest that the combination therapy could enhance bone health in osteoporosis.